Navigation Links
PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
Date:3/17/2009

PRINCETON, N.J., March 17 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company" , "PDGI" or "PharmaNet") (Nasdaq: PDGI), a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, announced that, pursuant to the terms of the indenture (the "Indenture") governing its 2.25% convertible senior notes due 2024 (the "Convertible Notes"), it anticipates that a "Fundamental Change" (as such term is defined in the Indenture) may occur as early as March 20, 2009, subject to the satisfaction or waiver of a number of conditions (the "Anticipated Effective Date").

As previously announced on February 12, 2009, JLL PharmaNet Holdings, LLC, a Delaware limited liability company ("Parent"), through PDGI Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser"), commenced a tender offer for all outstanding shares of PharmaNet at a price of $5.00 per share, net to the seller in cash (the "Offer"). On March 13, 2009, the expiration date of the Offer was extended until March 19, 2009, subject to possible further extension. The Offer was commenced pursuant to the terms of an Agreement and Plan of Merger, dated as of February 3, 2009 (the "Merger Agreement"), by and among Parent, PDGI and Purchaser. Parent and Purchaser are affiliates of JLL Partners Fund V, L.P. and JLL Partners Fund VI, L.P. (together, the "Sponsors"), each of which is a private equity investment fund managed by JLL Partners, a leading private equity investment fund ("JLL").

As previously disclosed, the completion of the Offer is subject to the satisfaction or waiver of a number of conditions set forth in the Merger Agreement, as described in the Offer to Purchase distributed by Parent, Purchaser and the Sponsors. Following the completion of the
'/>"/>

SOURCE PharmaNet Development Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
2. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
3. PharmaNet Development Group Agrees to be Acquired by JLL Partners
4. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
5. Med Discovery and Laborium Biopharma Extend Their Development Partnership to Include Mammalian Cell Culture Processes and Clinical Manufacturing for All Products in Med Discovery's Portfolio
6. Michael J. Fox Foundation Commits Up To $5 Million for Pre-Clinical Drug Development Under Industry-Exclusive Therapeutics Development Initiative
7. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
8. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
9. AMDL, Inc. Enters Into Collaboration Agreement to Advance Development of Its AMDL DR-70 (FDP) Cancer Test
10. Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
11. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 Empowering biomedical ... combat disease, Cubresa Inc. today announced its MR ... Compatible in-bore PET Scanner uses silicon photomultiplier detector ... preclinical MRI machines from manufacturers like Bruker and ... in Winnipeg, Canada. “This enables simultaneous PET and ...
(Date:5/27/2015)... 2015  US-Australian drug discovery and development company, Novogen Limited ... will present at the Brain Tumor Biotech Summit 2015, being ... 29, 2015. The venue is the Lennox Hill Hospital, East ... The Brain Tumor Biotech Summit brings together the ... the investment community to promote innovative new therapies for brain ...
(Date:5/26/2015)... Regenestem Network has announced the grand opening ... Argentina. The clinic will be lead by Silvina Pastrana, ... a multidisciplinary team of medical professionals who specialize in ... office. , The new Regenestem Network members plan ... in cellular therapies, and establish Regenestem protocols to isolate ...
(Date:5/26/2015)... RICHMOND, Calif. , May 26, 2015  Sangamo BioSciences, ... Lanphier , Sangamo,s president and CEO, will provide an update ... programs and an overview of the company,s business strategy at ... 2015 Global Healthcare Conference. The conference is being held in ... presentation will be webcast live and may be accessed via ...
Breaking Biology Technology:Cubresa Launches Simultaneous PET/MRI Technology 2Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... Scientists at the U.S. Department of Energy (DOE) Joint Genome ... and analysis of the complete genome of sorghum, a major ... crop. The genome data will aid scientists in optimizing ... use, but also for biofuels production. The comparative analysis ...
... innovator in the development and commercialization of sensing ... nuclear and explosive (CBRNE) materials, today announced that ... Ph.D. will be speaking at the 2009 International ... Wednesday, January 28, 2009, in Baltimore, Maryland. ...
... 28 Today the Swiss,pharmaceutical group Helsinn announced ... Inc. with headquarters in,Bridgewater, New Jersey, for an ... establishment of a US-based R&D and commercial operation ... strategic goals. "We are,thrilled at this very important ...
Cached Biology Technology:Scientists publish complete genetic blueprint of key biofuels crop 2JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market 2JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market 3JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market 4Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 2Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc. 3
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... chemists will be the basis of portable devices that ... Contaminated fingerprints leave dark shadows on the films, which ... can distinguish between different classes of explosive chemicals, a ... crime, or prevent one. A recent episode of ...
... Institute for Species Exploration at Arizona State University and ... species exploration and classification today announce the top ... list are an ornate sleeper ray, with a name ... shocking pink millipede; a rare, off-the-shelf frog; one of ...
... the Institute of Pacific Islands Forestry have submitted a ... spread of strawberry guava, a South American tree that ... was introduced in 1825 as a garden plant. The ... of Land and Natural Resources, and Hawai Department of ...
Cached Biology News:Glowing films developed by UC San Diego chemists reveal traces of explosives 2Scientists announce top 10 new species, issue SOS 2Scientists announce top 10 new species, issue SOS 3Scientists announce top 10 new species, issue SOS 4Insect release proposed to control exotic strawberry guava 2
... thermal cycler blocks, 96-well PCR plate, 0.3ml maximum ... seals), Cut-away corner , Fits all 0.2ml thermal ... capillary sequencers, Clear well bottom for sample visibility, ... Films and Foils, Heat Seals and Flat and ...
...
... and pathophysiological stressful conditions trigger the synthesis ... heat shock proteins (HSPs), more appropriately called ... Hsp90 family of proteins in mammalian cells ... and Trap-1 (Hsp75). It was found that ...
Custom LNA Oligonucleotide synthesis ,High quality Custom LNA Oligonucleotides are available for a variety of different specialty applications and innovative products. ,Please inquire for further...
Biology Products: